e.nilsen

TL2 Moderator · Kumasi

Contributes reviews on supplier material. Based in Kumasi.

Joined 25 November 2024 · last posted 5d

77 posts, newest first. Showing up to 150.

Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #105 · Evidence › Journal club · 23 Jul 2026 · 7 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #75 · Practice › Interactions · 22 Jul 2026 · 3 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
Compounds this community declines to help with, and why — does this still hold? Replied, post #7 · Compounds › Other compounds · 21 Jul 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Here for the analytics and not much else Replied, post #50 · Lounge › Introductions · 18 Jul 2026 · 5 likes Ongoing: you can post multiple introductions over time. If you return after a long break, reintroducing yourself is fine.
Selection into a registry and what it does to the estimate — a second dataset Replied, post #17 · Evidence › Study critique · 14 Jul 2026 · 14 likes Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #111 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 1 like Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #11 · Practice › Dosing & titration · 4 Jul 2026 · 0 likes I read post #9 twice before replying, because I had assumed the opposite. The four-week escalation interval is a convention from the pivotal trials, not a…
Why this subcategory is stricter about sourcing than most Replied, post #49 · Compounds › Secretagogues & GH axis · 28 Jun 2026 · 2 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #48 · Practice › Administration · 27 Jun 2026 · 23 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
Journal club: what we got wrong in an earlier session Replied, post #18 · Evidence › Journal club · 21 Jun 2026 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #61 · Outcomes › Progress reports · 17 Jun 2026 · 1 like I read post #59 twice before replying, because I had assumed the opposite. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability…
Journal club: what we got wrong in an earlier session Replied, post #6 · Evidence › Journal club · 15 Jun 2026 · 11 likes I read post #4 twice before replying, because I had assumed the opposite. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #23 · Documentation › Doc review · 14 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Search filters: what is missing Replied, post #65 · Meta › Site feedback · 4 Jun 2026 · 0 likes Coming back to post #63, because the follow-up matters more than the original answer. Accessibility: screen readers, keyboard navigation, contrast, font size — if…
Tracking a shortage from primary sources rather than rumour Replied, post #11 · Access › Shortages · 16 May 2026 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #41 · Compounds › Tirzepatide · 11 May 2026 · 1 like I read post #39 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #36 · Analytics › COA interpretation · 4 May 2026 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
A site rotation scheme that is easy enough to actually follow Replied, post #53 · Practice › Administration · 1 May 2026 · 11 likes Coming back to post #51, because the follow-up matters more than the original answer. A site rotation scheme that actually works: abdomen, outer thigh, back of arm,…
Personal import allowances, compared — a second dataset Replied, post #114 · Access › International · 1 May 2026 · 13 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
Prescription requirements and telehealth models — a second dataset Replied, post #16 · Sourcing › Regulatory · 30 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
The anatomy of a question that gets answered within an hour Replied, post #25 · Start Here › How to Ask · 22 Apr 2026 · 1 like The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #53 · Data & Tools › Datasets · 18 Apr 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Revisiting: Absolute versus relative contraindications Replied, post #69 · Safety › Contraindications · 18 Apr 2026 · 9 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
Foaming during reconstitution and whether it matters — the long version Replied, post #97 · Practice › Reconstitution · 13 Apr 2026 · 0 likes post #96 is right about the mechanism and I think understates the practical bit. Foaming during reconstitution: bubbles in the solution are usually just air…
Sample handling between despatch and injection Replied, post #31 · Analytics › Method validation · 10 Apr 2026 · 13 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
Spike-and-recover accuracy for a peptide assay Replied, post #88 · Analytics › Method validation · 10 Apr 2026 · 2 likes Coming back to post #86, because the follow-up matters more than the original answer. System suitability: injections run at the start of a batch to establish that the…
Follow-up: State-level differences that actually matter Replied, post #14 · Regional › North America · 4 Apr 2026 · 10 likes On post #10 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
A 10 mg vial reconstituted three different ways, compared Replied, post #11 · Practice › Reconstitution · 27 Mar 2026 · 0 likes I read post #9 twice before replying, because I had assumed the opposite. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL.…
Why the timeline is on the right and not the left — what changed since Replied, post #3 · Meta › Site feedback · 4 Mar 2026 · 10 likes Coming back to the opening post, because the follow-up matters more than the original answer. Bugs and friction: the parts of the site that do not work the way you…
Preprint servers and what screening they do Replied, post #72 · Evidence › Preprints · 28 Feb 2026 · 0 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #51 · Clinical › Bloodwork · 16 Feb 2026 · 0 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #18 · Pharmacology › Receptor biology · 19 Dec 2025 · 20 likes post #17 is right about the mechanism and I think understates the practical bit. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress…
Batch date after test date, and other internal inconsistencies Replied, post #27 · Analytics › COA interpretation · 15 Dec 2025 · 4 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
Documentation that materially improves an appeal's chances Replied, post #87 · Access › Insurance & coverage · 2 Dec 2025 · 0 likes I read post #85 twice before replying, because I had assumed the opposite. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite…
MHRA statements, read directly Replied, post #34 · Regional › UK & Ireland · 19 Nov 2025 · 10 likes Worth separating two things that post #30 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #54 · Compounds › Tirzepatide · 13 Nov 2025 · 1 like Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
Publishing an inconvenient result: a case study — the long version Replied, post #28 · Sourcing › Independent verification · 5 Nov 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #3 · Compounds › Semaglutide · 12 Oct 2025 · 2 likes post #2 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
New subcategory: rationale and scope Replied, post #4 · Meta › Announcements · 11 Oct 2025 · 1 like RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
The nausea timeline across the first four weeks, with a tabulated log Replied, post #56 · Practice › Side effects · 12 Sep 2025 · 28 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
High-resolution MS on aggregates and what it can see Replied, post #60 · Analytics › Mass spectrometry · 5 Sep 2025 · 9 likes Picking up post #57: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
A comparison of home results against a laboratory result on the same vial Replied, post #30 · Analytics › Home & field testing · 28 Aug 2025 · 4 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #13 · Data & Tools › Datasets · 23 Aug 2025 · 28 likes I read post #11 twice before replying, because I had assumed the opposite. Combining data from different sources: datasets from this site are not directly comparable to…
Revisiting: German, French and Dutch differences, compared Replied, post #62 · Regional › European Union · 22 Aug 2025 · 29 likes Coming back to post #60, because the follow-up matters more than the original answer. Germany: BfArM implements EU framework. Statutory insurance (the majority)…
Managing an unplanned gap in supply — what changed since Replied, post #39 · Access › Shortages · 16 Aug 2025 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. Resuming after a gap: after a gap of days or a few weeks, most people resume at…
A request that was declined, and the reasoning — a second dataset Replied, post #84 · Documentation › Wiki requests · 14 Aug 2025 · 0 likes post #83 is right about the mechanism and I think understates the practical bit. Cross-referencing: if you notice two pages that should reference each other but do not,…
Are there stupid questions here? A staff answer, at length Replied, post #69 · Start Here › Welcome · 13 Aug 2025 · 10 likes On post #65 — agreed on the reasoning, with one qualification. Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a…
Thyroid function tests during substantial weight change Replied, post #24 · Clinical › Bloodwork · 7 Aug 2025 · 4 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
Canadian access and provincial variation — one year on Replied, post #34 · Regional › North America · 26 Jul 2025 · 0 likes On post #30 — agreed on the reasoning, with one qualification. Indigenous healthcare systems: different indigenous healthcare systems have different medication access.…
Sequence verification for an obscure compound: how it is done Replied, post #105 · Compounds › Other compounds · 26 Jul 2025 · 16 likes post #104 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
Which panel is worth repeating and which is worth ignoring Replied, post #58 · Clinical › Bloodwork · 11 Jul 2025 · 9 likes Worth separating two things that post #54 runs together. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually…
Sodium, potassium and magnesium when intake drops Replied, post #45 · Nutrition & Training › Hydration & electrolytes · 5 Jul 2025 · 9 likes Picking up post #42: that is the part I would want checked first. Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and…
Discussing something you have already been doing — the long version Replied, post #4 · Clinical › Prescriber conversations · 5 Jul 2025 · 1 like Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #63 · Pharmacology › Pharmacokinetics · 24 Jun 2025 · 11 likes Picking up post #60: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #42 · Evidence › Trials · 31 May 2025 · 16 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #49 · Practice › Reconstitution · 8 May 2025 · 17 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #22 · Sourcing › Independent verification · 28 Apr 2025 · 13 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
Coverage for the indication versus for the drug Replied, post #41 · Access › Insurance & coverage · 24 Apr 2025 · 0 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #134 · Sourcing › Regulatory · 21 Apr 2025 · 7 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
Shakes versus food: a pragmatic assessment — the long version Replied, post #2 · Nutrition & Training › Protein & intake · 15 Apr 2025 · 3 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
When "no data" is the complete and final answer Replied, post #148 · Compounds › Other compounds · 14 Apr 2025 · 17 likes post #147 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Retatrutide dose escalation in the published trials Replied, post #56 · Compounds › Retatrutide · 27 Mar 2025 · 0 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
Scheduled maintenance and what will be unavailable Replied, post #79 · Meta › Announcements · 20 Mar 2025 · 25 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
About the Repair & healing peptides category Replied, post #3 · Compounds › Repair & healing peptides · 12 Mar 2025 · 1 like As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
Consistent declarations and why they matter more than clever ones Replied, post #139 · Sourcing › Logistics · 7 Mar 2025 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #40 · Sourcing › Regulatory · 1 Mar 2025 · 0 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
What we do not know about retatrutide, listed explicitly Replied, post #100 · Compounds › Retatrutide · 17 Feb 2025 · 9 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Reading an MS report that only gives you a single number Replied, post #10 · Analytics › Mass spectrometry · 13 Feb 2025 · 23 likes Coming back to post #8, because the follow-up matters more than the original answer. Mass accuracy is expressed in parts per million. It is the difference between…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #32 · Practice › Reconstitution · 13 Feb 2025 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #8 · Analytics › COA interpretation · 15 Jan 2025 · 24 likes post #7 answers the question as asked. The question underneath it is different. When method identifiers are missing: "reversed-phase HPLC" is less specific than…
EMA product information as a primary source — does this still hold? Replied, post #133 · Regional › European Union · 18 Nov 2024 · 3 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #16 · Compounds › Semaglutide · 8 Nov 2024 · 5 likes Picking up post #13: that is the part I would want checked first. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #58 · Practice › Administration · 26 Sep 2024 · 5 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
A rising related-substance total over six months: degradation or method drift? Replied, post #7 · Analytics › Impurities & related substances · 25 Aug 2024 · 12 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
Progressive overload when the scale is falling — one year on Started this topic · Nutrition & Training › Resistance training · 22 Aug 2024 · 31 likes Progressive overload when the scale is falling — one year on Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #20 · Nutrition & Training › Hydration & electrolytes · 31 Jul 2024 · 26 likes Worth separating two things that post #16 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #34 · Practice › Dosing & titration · 7 Jul 2024 · 7 likes Picking up post #31: that is the part I would want checked first. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base…